Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 12, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 14, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001140536-26-000007
Filed / recorded
Jan 14, 2026, 9:07 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
WILLIS TOWERS WATSON PLC
Issuer CIK
1140536
Ticker
WTW
Reporting person
Julie Jarecke Gebauer
Relationship
Officer
Officer title
Pres.-Health, Wealth & Career
Security
Restricted Share Unit
Table
Derivative (Table II)
Transaction date
Jan 12, 2026
Transaction code
A
Shares / units
12.0242
Price per share
$329.45
Acquired / disposed
Acquired (A)
Shares owned after
5,477.3278
Ownership form
Direct
Amendment
No
Footnotes from the filing
Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.
Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
A board member of Willis Towers Watson paid $67K out of pocket for Willis Towers Watson shares. 1 other person at Willis Towers Watson bought some too, in the same month. The Willis Towers Watson shares held grew by 11%.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.